Grace Peng

2.0k total citations
25 papers, 1.5k citations indexed

About

Grace Peng is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Grace Peng has authored 25 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 10 papers in Virology and 7 papers in Emergency Medicine. Recurrent topics in Grace Peng's work include HIV/AIDS drug development and treatment (16 papers), HIV/AIDS Research and Interventions (15 papers) and HIV Research and Treatment (10 papers). Grace Peng is often cited by papers focused on HIV/AIDS drug development and treatment (16 papers), HIV/AIDS Research and Interventions (15 papers) and HIV Research and Treatment (10 papers). Grace Peng collaborates with scholars based in United States, Japan and Australia. Grace Peng's co-authors include Rodger D. MacArthur, James D. Neaton, Donald I. Abrams, Winston Cavert, Joshua Rapkin, Jason V. Baker, Katherine Huppler Hullsiek, Cynthia L. Gibert, Judith C. Shlay and Michael J. Silverberg and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and Clinical Infectious Diseases.

In The Last Decade

Grace Peng

25 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Grace Peng United States	18	1.1k	790	578	430	105	25	1.5k
Adrián Curran Spain	26	972 0.9×	733 0.9×	423 0.7×	713 1.7×	36 0.3×	126	1.8k
Barry Peters United Kingdom	21	596 0.5×	454 0.6×	405 0.7×	292 0.7×	39 0.4×	50	1.3k
Teresa Bini Italy	17	622 0.5×	442 0.6×	313 0.5×	278 0.6×	71 0.7×	65	962
Susan L. Ford United States	22	1.5k 1.3×	1.1k 1.4×	215 0.4×	391 0.9×	27 0.3×	56	1.8k
Antonio Ocampo Spain	22	1.0k 0.9×	587 0.7×	223 0.4×	704 1.6×	11 0.1×	86	1.8k
Junko Tanuma Japan	19	814 0.7×	330 0.4×	274 0.5×	430 1.0×	18 0.2×	77	1.2k
Clara Gabiano Italy	18	694 0.6×	409 0.5×	308 0.5×	402 0.9×	23 0.2×	35	953
Chris Taylor United Kingdom	17	549 0.5×	149 0.2×	237 0.4×	559 1.3×	32 0.3×	49	1.2k
Duncan Churchill United Kingdom	17	720 0.6×	543 0.7×	284 0.5×	241 0.6×	13 0.1×	50	1.1k
Joan Romeu Spain	26	1.6k 1.4×	1.4k 1.8×	532 0.9×	524 1.2×	10 0.1×	67	2.3k

Countries citing papers authored by Grace Peng

Since Specialization

Citations

This map shows the geographic impact of Grace Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grace Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grace Peng more than expected).

Fields of papers citing papers by Grace Peng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grace Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grace Peng. The network helps show where Grace Peng may publish in the future.

Co-authorship network of co-authors of Grace Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Grace Peng. A scholar is included among the top collaborators of Grace Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grace Peng. Grace Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gardner, Edward M., Katherine Huppler Hullsiek, Edward E. Telzak, et al.. (2010). Antiretroviral medication adherence and class-specific resistance in a large prospective clinical trial. AIDS. 24(3). 395–403. 54 indexed citations

Shlay, Judith C., Shweta Sharma, Grace Peng, Cynthia L. Gibert, & Carl Grünfeld. (2009). The Effect of Individual Antiretroviral Drugs on Body Composition in HIV-Infected Persons Initiating Highly Active Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 51(3). 298–304. 20 indexed citations

Gardner, Edward M., Shweta Sharma, Grace Peng, et al.. (2008). Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance. AIDS. 22(1). 75–82. 97 indexed citations

Baker, Jason V., Grace Peng, Joshua Rapkin, et al.. (2008). CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS. 22(7). 841–848. 287 indexed citations

Baker, Jason V., Grace Peng, Joshua Rapkin, et al.. (2008). Poor Initial CD4+ Recovery With Antiretroviral Therapy Prolongs Immune Depletion and Increases Risk for AIDS and Non-AIDS Diseases. JAIDS Journal of Acquired Immune Deficiency Syndromes. 48(5). 541–546. 113 indexed citations

Gibert, Cynthia L., Judith C. Shlay, Shweta Sharma, et al.. (2008). Racial Differences in Changes of Metabolic Parameters and Body Composition in Antiretroviral Therapy-Naive Persons Initiating Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 50(1). 44–53. 8 indexed citations

Berg-Wolf, Mary van den, Katherine Huppler Hullsiek, Grace Peng, et al.. (2008). Virologic, Immunologic, Clinical, Safety, and Resistance Outcomes from a Long-Term Comparison of Efavirenz-Based Versus Nevirapine-Based Antiretroviral Regimens as Initial Therapy in HIV-1—Infected Persons. HIV Clinical Trials. 9(5). 324–336. 35 indexed citations

Shlay, Judith C., Shweta Sharma, Grace Peng, Cynthia L. Gibert, & Carl Grünfeld. (2008). Long-Term Subcutaneous Tissue Changes Among Antiretroviral-Naive Persons Initiating Stavudine, Zidovudine, or Abacavir With Lamivudine. JAIDS Journal of Acquired Immune Deficiency Syndromes. 48(1). 53–62. 11 indexed citations

Kozal, Michael J., Katherine Huppler Hullsiek, Rodger D. MacArthur, et al.. (2007). The Incidence of HIV Drug Resistance and Its Impact on Progression of HIV Disease Among Antiretroviral-Naïve Participants Started on Three Different Antiretroviral Therapy Strategies. HIV Clinical Trials. 8(6). 357–370. 41 indexed citations

10.

Shlay, Judith C., Glenn E. Bartsch, Grace Peng, et al.. (2007). Long-Term Body Composition and Metabolic Changes in Antiretroviral Naive Persons Randomized to Protease Inhibitor-, Nonnucleoside Reverse Transcriptase Inhibitor-, or Protease Inhibitor Plus Nonnucleoside Reverse Transcriptase Inhibitor-Based Strategy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(5). 506–517. 75 indexed citations

11.

MacArthur, Rodger D., Richard M. Novak, Grace Peng, et al.. (2006). A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial. The Lancet. 368(9553). 2125–2135. 101 indexed citations

12.

Shlay, Judith C., Fehmida Visnegarwala, Glenn E. Bartsch, et al.. (2005). Body Composition and Metabolic Changes in Antiretroviral-Naive Patients Randomized to Didanosine and Stavudine vs. Abacavir and Lamivudine. JAIDS Journal of Acquired Immune Deficiency Syndromes. 38(2). 147–155. 82 indexed citations

13.

Novak, Richard M., Rodger D. MacArthur, John D. Baxter, et al.. (2005). Prevalence of Antiretroviral Drug Resistance Mutations in Chronically HIV-Infected, Treatment-Naive Patients: Implications for Routine Resistance Screening before Initiation of Antiretroviral Therapy. Clinical Infectious Diseases. 40(3). 468–474. 104 indexed citations

14.

MacArthur, Rodger D., Grace Peng, Richard Novák, et al.. (2004). Efficacy and Safety of Abacavir Plus Lamivudine Versus Didanosine Plus Stavudine When Combined with a Protease Inhibitor, a Nonnucleoside Reverse Transcriptase Inhibitor, or Both in HIV-1 Positive Antiretroviral-Naive Persons. HIV Clinical Trials. 5(6). 361–370. 10 indexed citations

15.

Vázquez, José A., Grace Peng, Jack D. Sobel, et al.. (2001). Evolution of Antifungal Susceptibility amongCandidaSpecies Isolates Recovered from Human Immunodeficiency Virus–Infected Women Receiving Fluconazole Prophylaxis. Clinical Infectious Diseases. 33(7). 1069–1075. 45 indexed citations

16.

MacArthur, Rodger D., Li Chen, Douglas L. Mayers, et al.. (2001). The Rationale and Design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) Trial. Controlled Clinical Trials. 22(2). 176–190. 31 indexed citations

17.

Cohn, David L., Evelyn J. Fisher, Grace Peng, et al.. (1999). Prospective Randomized Trial of Four Three‐Drug Regimens in the Treatment of DisseminatedMycobacterium aviumComplex Disease in AIDS Patients: Excess Mortality Associated with High‐Dose Clarithromycin. Clinical Infectious Diseases. 29(1). 125–133. 43 indexed citations

18.

Vázquez, Federico, Jack D. Sobel, Grace Peng, et al.. (1999). Evolution of Vaginal Candida Species Recovered from Human Immunodeficiency Virus‐Infected Women Receiving Fluconazole Prophylaxis: The Emergence of Candida glabrata?. Clinical Infectious Diseases. 28(5). 1025–1031. 40 indexed citations

19.

Capps, Linnea, Grace Peng, Margaret Doyle, Wafaa El‐Sadr, & James D. Neaton. (1998). Sexually Transmitted Infections in Women Infected With the Human Immunodeficiency Virus. Sexually Transmitted Diseases. 25(8). 443–447. 17 indexed citations

20.

Peterson, B. A., Richard D. Brunning, Clara D. Bloomfield, et al.. (1987). Central nervous system involvement in acute nonlymphocytic leukemia. The American Journal of Medicine. 83(3). 464–470. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact